DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by Choreo LLC

Choreo LLC boosted its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 15.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,973 shares of the company’s stock after buying an additional 791 shares during the period. Choreo LLC’s holdings in DocuSign were worth $547,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. State Street Corp increased its stake in DocuSign by 2.3% during the third quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after acquiring an additional 120,743 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of DocuSign by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock worth $215,789,000 after purchasing an additional 53,554 shares during the period. Thrivent Financial for Lutherans increased its position in DocuSign by 5.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock worth $141,398,000 after purchasing an additional 112,919 shares in the last quarter. FMR LLC raised its holdings in DocuSign by 16.8% in the third quarter. FMR LLC now owns 2,192,885 shares of the company’s stock valued at $136,156,000 after buying an additional 315,073 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in DocuSign by 14.4% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,659,367 shares of the company’s stock valued at $103,030,000 after buying an additional 208,813 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

DocuSign Stock Down 3.2 %

DOCU stock opened at $87.92 on Wednesday. The stock’s 50 day moving average is $92.79 and its two-hundred day moving average is $74.72. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The company has a market capitalization of $17.76 billion, a PE ratio of 18.13, a P/E/G ratio of 7.56 and a beta of 0.89.

Insider Transactions at DocuSign

In other news, Director Daniel D. Springer sold 581,588 shares of the company’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the sale, the director now owns 906,430 shares in the company, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the transaction, the director now owns 7,736 shares of the company’s stock, valued at $731,825.60. This trade represents a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 685,773 shares of company stock valued at $66,032,726. 1.66% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

DOCU has been the subject of several recent research reports. Piper Sandler increased their price objective on shares of DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. increased their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. Jefferies Financial Group boosted their price objective on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $90.00 target price (up previously from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a research report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.